General Information of Drug (ID:
DR1291) |
Drug Name |
Pimozide
|
Synonyms |
Pimozida [INN-Spanish]; Pimozidum; Pimozidum [INN-Latin]; Primozida [INN-Spanish]; R 6238; R-6238; pimozida; pimozide; 1-(1-(4,4-Bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone; 1-(4,4-Bis(p-fluorophenyl)butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine; McN-JR 6238; McN-JR-6238; Opiran; 1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone; 1HIZ4DL86F; 2062-78-4; BRN 0729089; C28H29F2N3O; CCRIS 9172; CHEMBL1423; EINECS 218-171-7; MLS000028410; MLS002702058; NSC 170984; Orap; UNII-1HIZ4DL86F
|
Indication |
Schizophrenia
[ICD11: 6A20]
|
Approved
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
461.5 |
Topological Polar Surface Area |
35.6 |
Heavy Atom Count |
34 |
Rotatable Bond Count |
7 |
Hydrogen Bond Donor Count |
1 |
Hydrogen Bond Acceptor Count |
4 |
Cross-matching ID |
- PubChem CID
- 16362
- PubChem SID
-
9769
; 563187
; 855710
; 6706026
; 7847626
; 7980325
; 8137196
; 8149730
; 8162258
; 10321421
; 11111615
; 11112507
; 11113804
; 11335561
; 11360800
; 11363339
; 11365901
; 11368463
; 11372540
; 11373859
; 11376625
; 11447004
; 11461772
; 11466336
; 11467456
; 11484947
; 11486231
; 11488842
; 11491266
; 11492235
; 11494259
; 12013418
; 14882544
; 17405504
; 24277923
; 26612186
; 26680826
; 26747138
; 26747139
; 26751488
; 26751978
; 26751979
; 29284219
; 46507096
; 47275121
; 47275122
; 47423792
; 47572947
; 47720184
; 47720185
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D00KHM
- Formula
- C28H29F2N3O
- Canonical SMILES
- C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F
- InChI
- 1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)
- InChIKey
- YVUQSNJEYSNKRX-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.